Meten Holding Group Ltd. (METX) NASDAQ
2.03
+0.12(+6.28%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.03
+0.12(+6.28%)
Currency In USD
| Previous Close | 1.91 |
| Open | 1.91 |
| Day High | 2.04 |
| Day Low | 1.86 |
| 52-Week High | 9.93 |
| 52-Week Low | 1.75 |
| Volume | 11,653 |
| Average Volume | 179,739 |
| Market Cap | 3.1M |
| PE | 0.79 |
| EPS | 2.56 |
| Moving Average 50 Days | 2.81 |
| Moving Average 200 Days | 4.07 |
| Change | 0.12 |
Data not available
ME Therapeutics Announces It Has Engaged Lucosky Brookman LLP to Explore a Listing on the NASDAQ or NYSE
Newsfile
Mar 03, 2025 2:00 PM GMT
Vancouver, British Columbia--(Newsfile Corp. - March 3, 2025) - ME Therapeutics Holdings Inc. (CSE: METX) (FSE: Q9T) ("ME Therapeutics" or the "Company"), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field o